NEW Australian guidelines on osteoporosis (OP) stop short of recommending widespread screening for the condition, saying there is a lack of supporting evidence.
The guidelines also state that calcium and vitamin D supplements are more effective for people with a deficiency, and they should not be considered for routine use in healthy, non-institutionalised people or as first-line treatment for people with OP.
The importance of recognising patients with 'imminent' or 'very high' fracture risk is also highlighted, as this group may require early pharmacotherapy to activate bone formation.
The use of a fracture risk assessment tool such as FRAX for early recognition of poor bone health is encouraged.
See the guideline HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Apr 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Apr 25
